Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Gene linked to blood clots during cancer therapy

21 June 2010

By Dr Gabrielle Samuel

Appeared in BioNews 563

A new US study has found a gene mutation that can increase the risk of developing blood clots in breast cancer patients undergoing treatment with the drug tamoxifen.

Tamoxifen is the gold-standard treatment for hormone-sensitive breast cancer. Scientists looked at 412 women who were administered tamoxifen after breast cancer surgery and found that those who developed blood clots were five time more likely to carry the Factor V Leiden (FVL) gene.

Previous studies have already shown that the drug doubles the risk of blood clots in women, overall. But in people with the FVL gene mutation its impact is even bigger, scientists said, raising the risk of conditions such as deep vein thrombosis and pulmonary embolism - a potentially life-threatening blood clot on the lung.

The mutation is inherited and is more prevalent among people with northern European and Scandinavian ancestry. It is present in around 5 per cent of the UK population.

'These data may prove useful to women who must decide between tamoxifen and an effective, essentially non-thrombogenic, alternative adjuvant therapy for breast cancer', wrote lead researcher Dr Judy Garber and her team.

Possible tamoxifen alternatives included aromatase inhibitors for post-menopausal women, and gonadotrophin-releasing hormone analogues for pre-menopausal women.

The research was published in the Journal of the National Cancer Institute.

SOURCES & REFERENCES
Gene linked to blood clot danger
PharmacyEurope | 17 June 2010
 
Gene linked to cancer therapy risk
Press Association | 17 June 2010
 
Top News | 17 June 2010
 
Nursing Practice | 17 June 2010
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

16 May 2011 - by Dr Jay Stone 
US scientists have designed a genetic test which could predict how a patient with breast cancer responds to chemotherapy. Researchers say the test, which works for those with certain newly diagnosed forms of cancer, could help women avoid unnecessary chemotherapy....

14 June 2010 - by MacKenna Roberts 
The Australian Federal Court in Sydney is considering groundbreaking legal action of whether private companies can obtain patents on human genes....
07 June 2010 - by Dr Tamara Hirsch 
Women who inherit genes linked to breast cancer have no greater risk than other women of developing the disease as a result of lifestyle choices, including hormone replacement therapy (HRT) and alcohol consumption, according to a recent study in The Lancet....
07 June 2010 - by Dr Sophie Pryor 
US scientists have identified a region of DNA, which may contain a novel gene responsible for the progression and spread of colorectal (bowel) cancer....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation